Unichem Laboratories Announces Financial Results for Quarter Ended Sep 30, 2025
Unichem Labs announces results for quarter ended September 30, 2025. Consolidated total income from operations at ₹578.96 crore. Net loss before tax ₹10.82 crore and after tax ₹11.89 crore.
The financial results show a net loss, which could have a moderate impact on investor sentiment.
The announcement provides factual information regarding the company's financial results, without expressing any positive or negative outlook.
* Unichem Laboratories Limited has announced the financial results for the quarter and half year ended September 30, 2025. * The results were published in newspapers on November 12, 2025. * Consolidated total income from operations for the quarter ended September 30, 2025, was ₹578.96 crore. * Net loss for the period before tax was ₹10.82 crore. * Net loss for the period after tax was ₹11.89 crore. * Basic and diluted earnings per share were negative ₹1.69. * For the half year ended September 30, 2025, the consolidated total income from operations was ₹1,105.56 crore. * Net loss for the period before tax was ₹19.84 crore. * Net loss for the period after tax was ₹22.36 crore. * Effective April 30, 2025, Unichem Laboratories Ireland ceased to be a subsidiary, with a net gain of ₹1.99 crore recognized in the half year ended September 30, 2025. * The company and its subsidiary Niche Generics Ltd. settled a demand order from the European Commission for Euro 19.55 million, with a provision of Euro 13.96 million already recognized.
What to do with a filing like this
Unichem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Unichem Laboratories Limited. Read the original for the full detail.